BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 15978930)

  • 1. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
    Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
    Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes.
    Niens M; van den Berg A; Diepstra A; Nolte IM; van der Steege G; Gallagher A; Taylor GM; Jarrett RF; Poppema S; te Meerman GJ
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2280-4. PubMed ID: 17119058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.
    Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A
    Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
    J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Hodgkin's lymphoma after infectious mononucleosis.
    Hjalgrim H; Askling J; Rostgaard K; Hamilton-Dutoit S; Frisch M; Zhang JS; Madsen M; Rosdahl N; Konradsen HB; Storm HH; Melbye M
    N Engl J Med; 2003 Oct; 349(14):1324-32. PubMed ID: 14523140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Hodgkin's lymphoma with Epstein Barr virus infection.
    Cickusić E; Mustedanagić-Mujanović J; Iljazović E; Karasalihović Z; Skaljić I
    Bosn J Basic Med Sci; 2007 Feb; 7(1):58-65. PubMed ID: 17489771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigens and genetic susceptibility to lymphoma.
    McAulay KA; Jarrett RF
    Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve).
    Alexander FE; Jarrett RF; Cartwright RA; Armstrong AA; Gokhale DA; Kane E; Gray D; Lawrence DJ; Taylor GM
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):705-9. PubMed ID: 11401923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.
    Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S
    J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients.
    Fletcher LB; Veenstra RN; Loo EY; Hwang AE; Siddiqi IN; Visser L; Hepkema BG; Nolte IM; van den Berg A; Cozen W; Diepstra A
    PLoS One; 2017; 12(3):e0174457. PubMed ID: 28334025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus viral load and serology in childhood non-Hodgkin's lymphoma and chronic inflammatory conditions in Uganda: implications for disease risk and characteristics.
    Orem J; Sandin S; Mbidde E; Mangen FW; Middeldorp J; Weiderpass E
    J Med Virol; 2014 Oct; 86(10):1796-803. PubMed ID: 24889739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.
    Johnson PC; McAulay KA; Montgomery D; Lake A; Shield L; Gallagher A; Little AM; Shah A; Marsh SG; Taylor GM; Jarrett RF
    Int J Cancer; 2015 Sep; 137(5):1066-75. PubMed ID: 25648508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of Epstein-Barr virus infection in head and neck non-Hodgkin's lymphomas in Khorasan, northeast of Iran.
    Abadi RZ; Sistani NS; Mohtasham N; Hesari KK; Vaezi T; Pazouki M; Shakeri MT
    J Pak Med Assoc; 2013 Jul; 63(7):882-7. PubMed ID: 23901714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of Hodgkin lymphoma with Epstein-Barr virus in Hungary].
    Keresztes K; Bessenyei B; Szöllosi Z; Beck Z; Miltényi Z; Nemes Z; Oláh E; Illés A
    Orv Hetil; 2005 Jul; 146(30):1575-82. PubMed ID: 16136734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin's lymphoma in Indian children: prevalence and significance of Epstein-Barr virus detection in Hodgkin's and Reed-Sternberg cells.
    Dinand V; Dawar R; Arya LS; Unni R; Mohanty B; Singh R
    Eur J Cancer; 2007 Jan; 43(1):161-8. PubMed ID: 17113770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization.
    Valente G; Secchiero P; Lusso P; Abete MC; Jemma C; Reato G; Kerim S; Gallo RC; Palestro G
    Am J Pathol; 1996 Nov; 149(5):1501-10. PubMed ID: 8909240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
    de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
    HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.